Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - International journal of …, 2020 - Elsevier
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
[引用][C] Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - International Journal of …, 2020 - cir.nii.ac.jp
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label
randomised trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
randomised trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF][PDF] Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - International Journal …, 2020 - researchgate.net
abstract As no specific pharmacological treatment has been validated for use in coronavirus
disease 2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in …
disease 2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in …
Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial.
E Sekhavati, F Jafari, SA SeyedAlinaghi… - 2020 - cabidigitallibrary.org
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
E Sekhavati, F Jafari, S SeyedAlinaghi… - International Journal …, 2020 - europepmc.org
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
[HTML][HTML] Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - International Journal …, 2020 - ncbi.nlm.nih.gov
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - 2020 - pubmed.ncbi.nlm.nih.gov
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi… - 2020 - pubmed.ncbi.nlm.nih.gov
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …